Scientific and corporate news
Adipose-derived mesenchymal stem cells (AdMSCs) for the treatment of secondary progressive multiple sclerosis: A triple-blind, placebo-controlled, randomized phase I/II safety and feasibility study
Currently available treatments for secondary progressive multiple sclerosis (SPMS) have limited efficacy. Adipose-mesenchymal-derived stem cells (AdMSCs) represent a promising option and can be easily obtained
Stem Cell Storage: Intermediary companies fail, but there are still Biobanks to rely on like SSCB
“The failure and mismanagement of other Biobanks for Stem Cell Preservation ruin our sector”, speaks Dr. Luca Mariotta, Scientific Director of SSCB.
Last week, Ticinonews reported on a young couple who were looking for their baby’s cells after the company they had contracted with, Genico, disappeared. Cantonal pharmacist Giovan Maria Zanini said he was concerned about Switzerland’s free-market policy in such a sensitive area.
50,000 stem cell transplants worldwide
More than 50,000 transplants have been performed worldwide using haematopoietic stem cells. Umbilical cord stem cells are multi-potent cells: unspecialised mother cells, capable of self-renewal and of differentiating into different cell types each with specific functions.
Musculoskeletal disorders and mesenchymal stem cells
Considered to be one of the leading causes of disability worldwide, musculoskeletal disorders include osteoarthritis, rheumatoid arthritis, low back pain, osteoporosis, sarcopenia and myofascial pain
Fat as a source of stem cells for regenerative and aesthetic medicine
Did you know that SSCB offers you the possibility to store stem cells from fat tissue? Fat tissue is a rich source of stem cells
Stem cells: Did you know that there is great compatibility between siblings?
Stem cells are undifferentiated cells that are capable of forming the different cell types that make up an adult individual. Thanks to their ability to